IL1B and hyperinsulinemic hypoglycemia, familial, 4: Interestingly, there is very limited reports of efficacy of recombinant IL-1Ra or IL-1β inhibitors in animal models (except for IL1RN deficiency model), which are both approved biologics in SJIA.